SunRock Biopharma and GenScript ProBio Enter into a Collaboration [...] | Comunicati stampa CataniaOggi

22 febbraio 2021 10:13
Fonte: Adnkronos
#salute-e-benessere
NANJING, China, Feb. 22, 2021 /PRNewswire/ -- On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRock's CCR9 therapeutic antibody candidates. GenScript ProBio will provide SunRock Biopharma a one-stop-solution from antibody discovery, cell line development, process development to GMP drug substance and drug product manufacturing services.
By leveraging complementary strengths and capabilities, the parties are committed to the R&D, manufacturing process development, NMPA, FDA & EMA IND filings of CCR9 therapeutic antibodies, towards rapid development of novel antibody therapeutics.

Related Keywords

China ,Nanjing ,Jiangsu ,Sunrock Biopharma ,Genscript Probio ,Juan Buela ,Genscript Biotech Corporation Stock Code ,Script Probio ,General Manager ,Through Collaboration ,Brian Min ,About Sunrock Biopharma ,Genscript Biotech Corporation ,Stock Code ,Sun Rock ,Bio Pharma ,Hand ,Genscript ,Probio ,Center ,Into ,Collaboration , ,சீனா ,நான்ஜிங் ,ஜநரல் மேலாளர் ,மூலம் இணைந்து ,பிரையன் நிமிடம் ,ஸ்டாக் குறியீடு ,சூரியன் பாறை ,உயிர் பார்மா ,மற்றும் ,உள்ளிடவும் ,க்குள் ,இணைந்து ,